Men vs women with spontaneous intracerebral hemorrhage (ICH) have a higher risk for deep bleeds but a lower risk for poor outcomes.
CLPH-291 is under clinical development by Cellphire and currently in Phase II for Wiskott-Aldrich Syndrome. According to GlobalData, Phase II drugs for Wiskott-Aldrich Syndrome have a 100% phase ...
Over the past 3 decades, age-standardized stroke burden rates have declined worldwide, although some areas have seen increases in mortality rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback